Infiltration and extravasation.
Schulmeister
Lisa
L
D000931:Antidotes / Q000627:therapeutic use*; D017277:Drug Approval; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D009859:Oncology Nursing / Q000592:standards*; D017410:Practice Guidelines as Topic; D011929:Razoxane / Q000627:therapeutic use; D012956:Societies, Nursing; D014481:United States; D014486:United States Food and Drug Administration
D000931:Antidotes; D007509:Irritants; D011929:Razoxane